A discussion with Dr. Mark Burns, Assistant Professor of Neuroscience and Director of the Laboratory for Brain Injury and Dementia at Georgetown University, about his research on the link between traumatic brain injury (TBI) and Alzheimer's disease. This call was made possible by the generous support of Shawn Taylor, board member of USAgainstAlzheimer's Network.
A free teleconference series offered by USAgainstAlzheimer's Network covering a wide range of topics with leaders in the Alzheimer's community.
A discussion with Dr. Steven Arnold, Professor of Psychiatry and Neurology, University of Pennsylvania and Director of the Penn Memory Center and Dr. Gary Landreth, Professor of Neurosciences and Neurology and Director, Alzheimer's Research Laboratory, Case Western Reserve University School of Medicine. Dr. Arnold is conducting research into drug repurposing with a diabetes drug and Dr. Landreth is researching alternate uses for an existing cancer drug. They were introduced by Dr. Guy Eakin of BrightFocus Foundation, which funds some of this research.
This call was made possible by the generous support of the Emmanuel J. Friedman Philanthropies.
Women are two times more likely to die from Alzheimer’s disease. Can research focused on sex differences tell us why? And can it lead us to the effective prevention and treatment of Alzheimer’s?
Dr. Jill Goldstein, Professor of Psychiatry and Medicine at Harvard Medical School and Director of Research at the Connors Center for Women’s Health and Gender Biology at Brigham and Women’s Hospital, discussed this topic and answered questions.
This call was presented by WomenAgainstAlzheimer's. At the end of the call, Meryl Comer described this new network as well as the 2013 Geoffrey Beene Global NeuroDiscovery Challenge - focused on sex-based differences in Alzheimer's with over $100,000 in prizes.
Did you know that African Americans are twice as likely to develop Alzheimer's disease? We need to do all we can to eliminate this appalling health disparity – and the first step is to understand why it exists.
Dr. Laura D. Baker discussed her groundbreaking work, including whether things like exercise, diet, and nasal administration of insulin can slow the progression of Alzheimer's disease. Dr. Baker is an Associate Professor of Gerontology and Geriatric Medicine at Wake Forest Baptist Medical Center and affiliate faculty of Wake Forest's Maya Angelou Center for Health Equity.
This call was presented by the African American Network Against Alzheimer's and generously sponsored by Patrick Berry, a former Washington DC partner in the law firm of Baker Botts and a founding Board Member of USAgainstAlzheimer's.
Dr. Sperling is leading a groundbreaking new study on individuals whose brain scans show plaque buildups but do not yet demonstrate clinical symptoms of Alzheimer’s or other dementias. She will be testing the effectiveness of the Eli Lilly drug solanezumab, which in previous studies has shown might have promise with people that have a milder form of Alzheimer’s.
Dr. Sperling is the Director of the Center for Alzheimer's Research and Treatment, the Director of the Education and Information Transfer Core, Massachusetts Alzheimer's Disease Research Center, Co-Leader of the Neuroimaging Program, Massachusetts Alzheimer's Disease Research Center, and a Professor of Neurology at Harvard Medical School.
This call was made possible by the generous support of Jill Lesser, Board member of USAgainstAlzheimer's Network.